LRMR
Larimar Therapeutics, Inc.$2.98-0.04 (-1.32%)Prev Close$3.02·MCap$313.7M·P/E—·Vol2.10M·Yield—
▲
Buys (12M)
12
$26.10M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$26.10M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Larimar Therapeutics, Inc. (LRMR) has been exclusively buying, with 12 insider purchases totaling $26.10M and 0 insider sales totaling $0.00. The most recent insider transaction was by BEN-MAIMON CAROLE (director, officer: President and CEO), who purchased $50.0K worth of shares on Nov 12, 2026. Larimar Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $313.7M.
LRMR Insider Trading Activity
LRMR Insider Buying Activity
The following table shows recent insider purchases of Larimar Therapeutics, Inc. (LRMR) stock reported via SEC Form 4 filings.
LRMR Insider Selling Activity
The following table shows recent insider sales of Larimar Therapeutics, Inc. (LRMR) stock reported via SEC Form 4 filings.
No insider selling activity found for LRMR in the last 12 months.